Having established a strong association between STAT3-dependent cachexia-inducing cytokines in the RM9 system, we subsequently evaluated the effect of ruxolitinib and/or propranolol treatment in the RM9 in vivo cachexia model. Here, STAT3 is linked to Cachexia.